Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Hand of a person using a laptop.

    Thousands Respond to Survey on COVID-19 and Parkinson's Informing Our Understanding of the Pandemic

    MJFF-sponsored Fox Insight study releases results from first-of-its-kind survey on how COVID-19 is impacting the Parkinson’s community.
    Learn more
  • New Deep Brain Stimulation (DBS) System Approved for Parkinson's

    New Parkinson’s DBS Research: Does Not Increase Dementia Risk; May Help Earlier in Disease

    Two separate research studies report findings that could hone how deep brain stimulation (DBS) is delivered in Parkinson’s both now and in the future.
    Learn more
  • Watch and Learn: Gaining Insight on Parkinson's Using Wearable Technology

    Research Perspective: The Growing Importance of Digital Disease Measures

    MJFF scientists explore the current state of remote monitoring of Parkinson’s disease, including tools and analysis, and look to what’s ahead for the field.
    Learn more
  • Ask the MD: Expanded Indication for DBS in Parkinson's

    FDA Approves New DBS Device that Measures Brain Activity

    The latest deep brain stimulation device offers a new tool to help optimize treatment: the device itself.
    Learn more
  • ProSavin Trial Results: Once Again, a Gene Therapy Approach to Parkinson’s Yields Encouraging Safety Data but Modest Efficacy

    What We Fund: $16.5 Million in New Grants for Parkinson’s Research

    The Foundation recently funded 19 new projects at a total of $16.5 million to continue advancing critical Parkinson's research.
    Learn more
  • Two researchers in lab looking at samples

    PPMI Dispatch: Closer to Predicting Disease Progression and Symptoms

    Findings from our Parkinson’s Progression Markers Initiative study point to potential ways to measure progression and predict disease.
    Learn more
  • Female researcher in lab with pipette.

    Nuplazid Submitted to FDA for Treating Psychosis in People with Dementia

    Nuplazid, approved to treat psychosis in people with Parkinson’s, now is at the FDA for potential expanded use to treat psychosis in people with dementia.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.
Here. Until Parkinson's isn't.
Join us as we work to find a cure for the 6 million people worldwide living with Parkinson's.
 
 
 
 
Month
Day
Year